Clinical and molecular aspects of androgen insensitivity

Endocrine Development

Volumn 24, Issue , 2013, Pages 33-40

  Hiort, Olaf ^a  

^a UNIVERSITY OF LÜBECK   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ANDROGEN; ANDROGEN RECEPTOR; TRANSCRIPTION FACTOR;

ANDROGEN INSENSITIVITY SYNDROME; ARTICLE; CELL SPECIFICITY; CONGENITAL ADRENAL HYPERPLASIA; GENE CONTROL; GENE LOCATION; GENE MUTATION; GENETIC TRANSCRIPTION; GENETICS; GYNECOMASTIA; HUMAN; KARYOTYPE 46,XY; MALE INFERTILITY; MOLECULAR BIOLOGY; NUCLEAR REPROGRAMMING; PHENOTYPE; PRIORITY JOURNAL; SEXUAL DEVELOPMENT; VIRILIZATION; X CHROMOSOME; AMBIGUOUS GENITALIA; ANDROGEN THERAPY; ESTROGEN THERAPY; PARENT COUNSELING; UROLOGIC SURGERY;

ANDROGEN-INSENSITIVITY SYNDROME; DISORDERS OF SEX DEVELOPMENT; FEMALE; GENITALIA; HUMANS; MALE; RECEPTORS, ANDROGEN;

EID: 84875416683     PISSN: 14217082     EISSN: 16622979     Source Type: Book Series    
DOI: 10.1159/000342499     Document Type: Article

References (22)

1. Hughes IA, Houk C, Ahmed SF, Lee PA, LWPES Consensus Group, ESPE Consensus Group: Consensus statement on management of intersex disorders. Arch Dis Child 2006;91:554-563.
2. Quigley CA, De Bellis A, Marschke KB, El-Awady M, Wilson EM, French FS: Androgen receptor defects: historical, clinical and molecular perspectives. Endocr Rev 1995;16:271-322.
3. Sinnecker GH, Hiort O, Nitsche EM, Holterhus PM, Kruse K: Functional assessment and clinical classification of androgen sensitivity in patients with mutations of the androgen receptor gene. German Collaborative Intersex Study Group. Eur J Pediatr 1997;156:7-14.
4. Werner R, Gr?sch H, Hiort O: 46,XY disorders of sex development-the undermasculinised male with disorders of androgen action. Best Pract Res Clin Endocrinol Metab 2010;24:263-277.
5. Gr?sch H, Kunert M, Mooslehner KA, Gao Z, Struve D, Hughes IA, Hiort O, Werner R: RWDD1 interacts with the ligand binding domain of the androgen receptor and acts as a coactivator of androgen-dependent transactivation. Mol Cell Endocrinol 2012;358:53-62.
6. Holterhus PM, Piefke S, Hiort O: Anabolic steroids, testosterone- precursors and virilizing androgens induce distinct activation profiles of androgen responsive promoter constructs. J Steroid Biochem Molec Biol 2002;82:269-275.
7. Werner R, Holterhus PM, Binder G, Schwarz HP, Morlot M, Struve D, Marschke C, Hiort O: The A645D mutation in the hinge region of the human AR gene modulates AR activity depending on the context of the polymorphic glutamine and glycine repeats. J Clin Endocrinol Metab 2006;91:3515-3520.
8. Werner R, Zhan J, Gesing J, Struve D, Hiort O: Invitro characterization of androgen receptor mutations associated with complete androgen insensitivity syndrome reveals distinct functional deficits. Sex Dev 2008;2:73-83.
9. Hiort O, Holterhus PM, Horter T, Schulze W, Kremke B, Bals-Pratsch M, Sinnecker GHG, Kruse K: Significance of mutations in the androgen receptor gene in males with idiopathic infertility. J Clin Endocrinol Metab 2000;85:2810-2815.
10. Hiort O, Sinnecker GHG, Holterhus PM, Nitsche EM, Kruse K: Inherited and de novo androgen receptor gene mutations: investigation of singlecase families. J Pediatr 1998;131:939-943.
11. Holterhus PM, Hiort O, Demeter J, Brown PO, Brooks JD: Differential gene expression patterns in genital fibroblasts of normal and 46,XY-females with androgen insensitivity syndrome: evidence for early programming involving the androgen receptor. Genome Biol 2003;4:R37.
12. Holterhus PM, Deppe U, Werner R, Richter-Unruh A, Bebermeier JH, Wunsch L, Krege S, Schweikert HU, Demeter J, Riepe F, Hiort O, Brooks JD: Intrinsic androgen-dependent gene expression patterns revealed by comparison of genital fibroblasts from normal males and individuals with complete and partial androgen insensitivity syndrome. BMC Genomics 2007;18:376.
13. Holterhus PM, Bebermeier JH, Werner R, Demeter J, Richter-Unruh A, Cario G, Appari M, Siebert R, Riepe F, Brooks JD, Hiort O: Disorders of sex development expose transcriptional autonomy of genetic sex and androgen-programmed hormonal sex in human blood leukocytes. BMC Genomics 2009; 10:292.
14. Appari M, Werner R, W?sch L, Cario G, Demeter J, Hiort O, Riepe F, Brooks JD, Holterhus PM: Apolipoprotein D (APOD) is a putative biomarker of androgen receptor function in androgen insensitivity syndrome. J Mol Med 2009;87:623-632.
15. Bouvattier C, Carel JC, Lecointre C, David A, Sultan C, Bertrand AM, Morel Y, Chaussain JL: Postnatal changes of T, LH, and FSH in 46,XY infants with mutations in the AR gene. J Clin Endocrinol Metab 2002;87:29-32.
16. Ahmed SF, Cheng A, Hughes IA: Assessment of the gonadotrophin-gonadal axis in androgen insensitivity syndrome. Arch Dis Child 1999;80:324-329.
17. Papadimitriou DT, Linglart A, Morel Y, Chaussain JL: Puberty in subjects with complete androgen insensitivity syndrome. Horm Res 2006;65:126-131.
18. K?ler B, Kleinemeier E, Lux A, Hiort O, Gr?ers A, Thyen U, the DSD Network Working Group: Satisfaction with genital surgery and sexual life of adults with XY disorders of sex development: results from the German Clinical Evaluation Study. J Clin Endocrinol Metab 2012;97:577-588.
19. Cools M, Wolffenbuttel KP, Drop SL, Oosterhuis JW, Looijenga LH: Gonadal development and tumor formation at the crossroads of male and female sex determination. Sex Dev 2011;5:167-180.
20. Warne GL, Grover S, Zajac JD: Hormonal therapies for individuals with intersex conditions: protocol for use. Treat Endocrinol 2005;4:19-29.
21. Bertelloni S, Dati E, Baroncelli GI, Hiort O: Hormonal management of complete androgen insensitivity syndrome from adolescence onward. Horm Res Paediatr 2011;76:428-433.
22. Ahmed SF, Rodie M, Jiang J, Sinnott RO: The European disorder of sex development registry: a virtual research environment. Sex Dev 2010;4:192-198.